BIO KEY INTERNATIONAL INC (BKYI) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$2.52

From 52W high−75.24%

Volume20784.00

Market cap$3.66M

P/E (TTM)—

P/S (TTM)0.5x

Div yield—

Key dataSep 18, 2026

Open

$2.52

From 52W high

−75.24%

Volume

20784.00

Market cap

$3.66M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.8x

P/E (TTM)

—

RSI (14)

28.1

MomentumView details →

1D Return

−0.58%

YTD Return

−52.50%

SummaryUpdated Jun 1, 2026

BIO-key International, Inc. (NASDAQ:BKYI) is a cybersecurity company founded in 1993 and headquartered in Wall, New Jersey. Originally known as SAC Technologies, the company changed its name to BIO-key International in 2002 and went public in 1997. The company specializes in biometric authentication and identity access management solutions, serving commercial, government, and educational customers in the United States and internationally. After decades of development, BIO-key has positioned itself as a provider of fingerprint-based biometric technology and cloud-based identity platforms, though it remains a small-cap company working toward profitability.

Ask drillr about BIO KEY INTERNATIONAL INC →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.8x

EV/Sales

0.4x

P/S (TTM)

0.5x

P/B (TTM)

0.8x

ProfitabilityView details →

Gross Margin

81.75%

Net Margin

−50.00%

EBITDA Margin

−43.78%

ROE (TTM)

−79.09%

ROA (TTM)

−45.81%

Asset Turnover

0.75x

GrowthView details →

Revenue YoY

−0.79%

EPS YoY

+55.62%

FCF YoY

−18.00%

Revenue CAGR 3Y

−4.60%

EPS CAGR 3Y

+48.42%

EBITDA YoY

+6.94%

MomentumView details →

1D Return

−0.58%

YTD Return

−52.50%

1Y Return

−66.97%

RSI (14)

28.1

vs 50D SMA

−29.61%

vs 200D SMA

−50.48%

Capital & dividendView details →

Debt/Equity

0.03x

Current Ratio

1.26x

Quick Ratio

1.14x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.56

EPS Surprise

31.71%

Beats (12Q)

6/12

Next Q EPS Est

−$0.35

Avg Surprise (4Q)

−22.43%

Rev Surprise

6.67%

Financials snapshotView financials →

Revenue (TTM)

6.86M

Net Income (TTM)

−3.43M

Op. CF (TTM)

−4.15M

Next earningsNov 13, 2026 →

Latest newsMore news →

BIO-key reported a 51% improvement in bottom line and a 13% rise in Q2 revenues, driven by strength with government, defense, and financial sector customers globally.38d ago

BIO-key International Inc. entered into a Warrant Exercise Agreement with an existing institutional investor, reducing the exercise price of existing warrants from $10.20 to $4.06 per share and issuing new 200% covered warrants for up to 1,236,668 common shares, raising approximately $2.51 million in gross proceeds.39d ago

Similar companies

Iveda Solutions, Inc.IVDA Bridger Aerospace Group Holdings, Inc. WarrantBAERW Guardforce AI Co., LimitedGFAI VerifyMe, Inc.VRME Concorde International Group Ltd Class A Ordinary SharesCIGL LogicMark, Inc.LGMK Find similar companies →

Latest newsMore news →

BIO-key reported a 51% improvement in bottom line and a 13% rise in Q2 revenues, driven by strength with government, defense, and financial sector customers globally.38d ago BIO-key International Inc. entered into a Warrant Exercise Agreement with an existing institutional investor, reducing the exercise price of existing warrants from $10.20 to $4.06 per share and issuing new 200% covered warrants for up to 1,236,668 common shares, raising approximately $2.51 million in gross proceeds.39d ago